For the year ending 2025-12-31, IMA made $800K in revenue. -$52,395K in net income. Net profit margin of -6549.38%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| License revenue | 800 | |||
| Research and development | 28,525 | |||
| General and administrative | 20,726 | |||
| Total operating expenses | 49,251 | |||
| Loss from operations | -48,451 | |||
| Interest income (expense), net | 2,035 | |||
| Other income (expense), net | 717 | |||
| Total other income, net | 2,752 | |||
| Loss before income taxes | -45,699 | |||
| Income tax benefit (provision) | -350 | |||
| Net loss | -45,349 | |||
| Accretion of redeemable convertible preferred shares | 7,046 | |||
| Net income (loss) available to common stockholders, basic, total | -52,395 | |||
| Basic EPS | -9.64 | |||
| Diluted EPS | -9.64 | |||
| Basic Average Shares | 4,870,906 | |||
| Diluted Average Shares | 4,870,906 | |||
ImageneBio, Inc. (IMA)
ImageneBio, Inc. (IMA)